Lung Cancer Trials Ask AI to find trials
RecruitingPhase 3NCT06810375
Official study title

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

Study summary

This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedErector Spinae (ESP) Block with Bupivacaine (Marcaine®) and Intercostal nerve block

The study team can explain what participation involves.

Who it may be forLung Cancers

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 9, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Phase 3

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?George Washington University

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 3
Sponsor
George Washington University
Interventions being studied
Drug: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®); Drug: Intercostal nerve block
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Surgery→
Study topics
After surgery (adjuvant)→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Video assisted pulmonary resection, pleurodesis or decortication

Reasons someone may not be able to joinExclusion criteria
  • Allergy to local anesthetics
  • Patient undergoing bilateral surgery
  • Surgery is emergent as deemed by the principal investigator

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • The George Washington University HospitalWashington D.C., District of Columbia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 9, 2026. Always confirm current availability with the study team.

View original record ↗